Dr. Christopher E Silva is a Gettysburg, Pennsylvania based psychologist with 35 years of experience in General Psychology. He completed his graduation in 1990. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Christopher E Silva is PS008466L for Clinical Psychology in Pennsylvania. His current practice location is 40 V Twin Dr, Ste 202, Gettysburg. Patients can reach him at 717-339-2710 or can fax him at 717-339-2711. Dr. Christopher E Silva is PHD in General Psychology and his NPI number (Unique professional ID assigned by NPPES) is 1053355453. Dr. Christopher E Silva is specialized in psychological testing and evaluating or assessing patient's personal characteristics, such as intelligence, personality, abilities, interests, aptitudes, and neuropsychological functioning. Accordingly, he performs counseling, psychoanalysis, psychotherapy, hypnosis, biofeedback, and behavior analysis and therapy. He can diagnose and treat mental and emotional disorder or disability, alcoholism and substance abuse, disorders of habit or conduct, as well as of the psychological aspects of physical illness, accident, injury, or disability by psycheducational evaluation, therapy, remediation, and consultation.
Complete Profile:
Dr. Christopher E Silva speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Christopher E Silva
Specialization:
General Psychology
Gender:
Male
Credentials:
PHD
Experience:
35+ years
Medical School Attended:
Other
Graduation Year:
1990
Accepts Medicare Assignment:
Yes
Practice Address:
40 V Twin Dr, Ste 202, Gettysburg, Pennsylvania, 17325-1926
Phone:
717-339-2710
Fax:
717-339-2711
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3577751536
Enrollment ID:
I20101217000664
NPI Number:
1053355453
NPI Enumeration Date:
15 Jun, 2006
NPI Last Update On:
22 Sep, 2014
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Christopher E Silva are as mentioned below.
License Number
Specialization
State
Status
PS008466L
Clinical Psychology
Pennsylvania
Primary
PS008466L
General Psychology
Pennsylvania
Secondary
PS008466L
Cognitive & Behavioral Psychology
Pennsylvania
Secondary
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Christopher E Silva is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Wellspan Medical Group (1951213115)
1425
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Christopher E Silva such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2134298
Other
Pennsylvania
CIGNA BEHAVIORAL HEALTH
284685
Other
Pennsylvania
MAMSI
607931
Other
Pennsylvania
BC/BS OF MD CARE FIRST
162689
Other
Pennsylvania
VALUE OPTIONS
01094001
Other
Pennsylvania
CAPITAL BLUE CROSS
276789000
Other
Pennsylvania
MAGELLAN
SI559670
Other
Pennsylvania
PA BLUE SHIELD
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Christopher E Silva 3421 Concord Rd, York, Pennsylvania
Zip:
17402-9001
Phone Number:
717-339-2710
Fax Number:
717-339-2711
Patients can reach Dr. Christopher E Silva at 40 V Twin Dr, Ste 202, Gettysburg, Pennsylvania or can call to book an appointment on 717-339-2710.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.